Rare diseases
Investigational molecules
Locations
A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
PolandA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
PolandStudy of MT-501 in patients with active Crohn's Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial
PolandTitle: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease
PolandStudy of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease
PolandStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
PolandStudy comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery
PolandEvaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
PolandLong-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031
PolandStudy comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy
PolandStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
PolandStudy of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
